SUPREME COURT SEEKS ADMINISTRATION'S OPINION ON IDE APPROVAL PREEMPTION OVER TORT CLAIMS; IOLAB PETITION QUESTIONS APPLICABILITY OF MEDTRONIC V. LOHR
This article was originally published in The Gray Sheet
Executive Summary
The Administration is expected to file in 60-90 days its opinion on whether FDA's Investigational Device Exemption regulation preempts state tort claims in response to a case before the U.S. Supreme Court.
You may also be interested in...
Supreme Court Seeks Solicitor General’s Input On PMA Preemption
The U.S. Supreme Court is considering whether to hear a potentially far-reaching case on whether patients injured by PMA-approved devices can sue manufacturers under state laws
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.